title: Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery.
authors.affiliation: Institute of Endocrinology and Nutrition, Medicine School, Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain. dadluis@yahoo.es
authors.forename: Daniel Antonio
authors.initials: DA
authors.lastname: de Luis
authors.forename: Olatz
authors.initials: O
authors.lastname: Izaola
authors.forename: Rosa
authors.initials: R
authors.lastname: Conde
authors.forename: David
authors.initials: D
authors.lastname: Primo
authors.forename: Manuel González
authors.initials: MG
authors.lastname: Sagrado
authors.forename: Rocio
authors.initials: R
authors.lastname: Aller
mesh_terms: D015904:Biliopancreatic Diversion / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D003920:Diabetes Mellitus; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D050152:Intra-Abdominal Fat / Q000378:metabolism; D008875:Middle Aged; D054409:Nicotinamide Phosphoribosyltransferase / Q000096:biosynthesis / Q000097:blood*; D009767:Obesity, Morbid / Q000097:blood / Q000601:surgery*; D011184:Postoperative Period; D011446:Prospective Studies; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D015415:Biomarkers; D054409:Nicotinamide Phosphoribosyltransferase